# Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)

> **NCT06093269** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 32 (actual)

## Conditions studied

- Hemodialysis Catheter Infection
- Infection, Bacterial

## Interventions

- **BIOLOGICAL:** Blood samples

## Key facts

- **NCT ID:** NCT06093269
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-20
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06093269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06093269, "Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06093269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*